Introduction





Products Description
1. Introduction
Structurally, ACE-031 is formed by fusing the extracellular binding region of the myostatin receptor (ActRIIB) with the Fc fragment of human immunoglobulin IgG1. This structural design gives it both highly efficient targeting binding and a long plasma half-life, thus significantly enhancing its bioavailability and stability. As a high-quality peptide raw material, ACE-031 possesses both scientific research value and clinical potential, and has become one of the core molecules in muscle growth and metabolism research.
2. Classification and Uses
Based on its uses and production standards, ACE-031 can be classified into the following categories:
Pharmaceutical-grade ACE-031: Primarily used in preclinical research and drug development stages. Its purity is typically above 98%, produced using high-level cell expression systems (such as CHO cells), and undergoes rigorous purification and quality control procedures. This type of product must meet GMP standards and is used for experimental treatment of diseases such as muscular dystrophy and cancer wasting disorders.
Research-grade ACE-031: Widely used in molecular biology, pharmacology, and cell signaling pathway research. This grade prioritizes functional activity and batch-to-batch consistency, used to validate the mechanisms of action of ACE-031 in muscle tissue growth, bone density regulation, and metabolic homeostasis. Purity is generally above 95%, suitable for laboratory animal studies.
Industrial or intermediate grade ACE-031: These products are primarily used in downstream formulation development or as intermediates for structural modification. Although purity is slightly lower (90–95%), they still have practical value in industrial research and biological reaction optimization.
3. Physicochemical Properties
ACE-031 is a medium-to-large molecular weight protein/peptide compound with the following physicochemical characteristics:
Molecular Formula: C₂₆₈₆H₄₁₆₂N₇₁₄O₈₃₁S₁₆ (Theoretical molecular formula, specific formula may vary slightly depending on the expression system)
Molecular Weight: Approximately 95–105 kDa (depending on glycosylation level)
Structural Characteristics: A dimer fusion protein composed of the extracellular domain of ActRIIB and the Fc segment of IgG1, exhibiting a stable symmetrical structure and good three-dimensional conformational stability.
Isoelectric Point (pI): Approximately 6.8 to 7.2
Solubility: Soluble in PBS buffer, physiological saline, and buffer systems containing 0.1% Tween-20; insoluble in organic solvents.
Stability: In its lyophilized powder form, it can be stably stored at -20℃ for more than two years; in solution form, it can be stored at 4℃ for approximately two weeks.
Appearance-wise, ACE-031 is a white or off-white lyophilized powder with a light and fine texture and low hygroscopicity. After dissolving, it forms a colorless, transparent, or slightly milky-white solution. If the color is yellowish or turbid, it usually indicates that the protein has undergone partial degradation or aggregation.
4. Mechanism of Action
The main mechanism of action of ACE-031 is based on its blocking function against myostatin and related signaling pathways. Myostatin is a cytokine of the TGF-β family and a negative factor regulating skeletal muscle growth. ACE-031 competitively binds to myostatin and activin A ligands, preventing them from binding to the natural ActRIIB receptor, thereby blocking its downstream Smad2/3 signaling pathway, thus promoting muscle protein synthesis and reducing muscle breakdown.
Furthermore, studies have found that ACE-031 can also:
increase muscle fiber diameter and density;
improve bone mineral content and bone density;
regulate lipid metabolism and insulin sensitivity;
and demonstrate significant anti-muscle atrophy and anti-bone loss effects in animal experiments.
These properties make ACE-031 not only a therapeutic potential but also a key molecular tool for studying muscle metabolism and regeneration.
5. Advantages and Characteristics
High Bioactivity and Specificity
Through targeted binding to the ActRIIB ligand, ACE-031 exhibits extremely strong affinity and selectivity at the molecular level, effectively interrupting myogenic inhibitory signals, thereby enhancing muscle tissue synthesis.
Excellent Pharmacokinetic Performance
The Fc fusion structure significantly prolongs its half-life in vivo, allowing its activity in animals to last for several days, reducing the frequency of administration.
High Purity and Low Immunogenicity
Produced using a mammalian cell expression system, its glycosylation modification is closer to that of human proteins, resulting in low immunogenicity.
Good Stability and Formulation Applicability
The raw material powder form is easy to store and transport, and can be readily dissolved in conventional buffer systems to prepare injections or other formulations.
Potential Clinical Application Prospects
Multiple animal experiments and early clinical data have shown that ACE-031 can significantly increase muscle mass and bone mineral density, showing broad prospects in the treatment of hereditary muscular dystrophy and osteoporosis.
6. Production and Quality Control
ACE-031 is usually expressed in CHO (Chinese hamster ovary) cells using gene recombination technology. The production process includes:
Constructing the fusion gene and introducing it into the expression vector;
Achieving high expression in cell culture;
Purification by protein A affinity chromatography and ion exchange chromatography;
Frecrystallization and aseptic packaging.
For quality control, multiple methods are required for testing:
SDS-PAGE: To assess purity and dimer formation;
Western Blot: To confirm the Fc fusion structure;
HPLC analysis: To detect purity and homogeneity;
Endotoxin test: To ensure that the endotoxin content is below the safety limit;
Bioactivity test: To verify its inhibitory ability on the Myostatin signaling pathway.
7. Storage and Handling Conditions
The lyophilized powder should be stored below −20°C in a light-proof and moisture-proof environment. After reconstitution, it should be handled under aseptic conditions. For short-term storage, a temperature of 4°C is recommended. Avoid repeated freeze-thaw cycles to prevent protein aggregation or inactivation. For long-term storage, the solution should be aliquoted and rapidly frozen at −80°C.
8. Safety and Precautions
In animal studies and early clinical trials, ACE-031 has generally shown good safety, but the following precautions should be taken:
Mild vasodilatory reactions or nosebleeds may occur due to slight interference with angiogenesis signals by ACE-031;
Long-term high-dose use may affect reproductive hormone balance;
The safety of use in individuals with weakened immune systems should be carefully assessed.
Research-grade products are for experimental use only and must not be used for direct human injection or clinical treatment.
9. Appearance and Quality Assessment
High-quality ACE-031 powder should be a uniform white or slightly milky white lyophilized mass, highly stable in air, and should not exhibit significant moisture absorption or clumping. The dissolved solution should be clear and transparent. If turbidity, precipitation, or darkening of the color occurs, it indicates possible protein denaturation or contamination, and the product should not be used. High-quality products should show a single main band in electrophoresis, without obvious peaks of other proteins.
10. Summary and Future Prospects
ACE-031, as a high-end recombinant peptide biologic, has become an important tool in the field of muscle growth research due to its superior structural design, stable physicochemical properties, and significant biological efficacy. It has not only advanced the understanding of myogenic inhibition mechanisms but also brought new directions to the treatment of various muscle atrophy diseases.
In the future, with advancements in protein engineering and long-acting formulation technologies, ACE-031 is expected to further optimize its half-life and targeting, and may even be combined with gene therapy and stem cell therapy to form a systematic muscle repair solution. At the same time, continuously improving quality standards and safety assessment systems will ensure its reliable application in scientific research and the pharmaceutical industry.
Overall, ACE-031 represents the development trend of a new generation of bioactive peptides. Its excellent physicochemical properties, broad application prospects, and scientific preparation system make it an important bridge connecting scientific research and clinical translation.
Supported Payment Methods And Contact Us
Supported payment methods
We support multiple payment methods





Contact Us
You can contact us via WhatsApp, Telegram, Gmail, Proton Mail, etc.





Hot Tags: premium high-purity peptides ace-031 1mg, China premium high-purity peptides ace-031 1mg manufacturers, suppliers, factory, Follistatin 344 Enhance the vitality and growth rate of muscle cells, ACE 031 Add muscle mass and volume, Ipamorelin Protect muscle tissue, PEG MGF CAS 62031 54 3, Hexarelin CAS 140703 51 1, Follistatin 344 and Fst 344
